(Pink Sheets: CJGH),(OTCBB: CVBT), (OTCBB: GTRE), (Pink Sheets: WMAN).

RealPennies.com: Turning Pennies into dollars: (Pink Sheets: CJGH),(OTCBB: CVBT), (OTCBB: GTRE), (Pink Sheets: WMAN).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://cjgh.realpennies.com

EGPI Firecreek, Inc. (OTCBB: CJGH)

China Jiangsu Golden Horse Steel Ball, Inc. (Pink Sheets: CJGH ) (January 7, 2008) China Jiangsu Golden Horse Steel Ball, Inc., a leading Chinese manufacturer and supplier of ball bearings, wishes to announce that it is seeking a European listing, specifically on the Frankfurt Stock Exchange. Management feels that this will be an important move in order to broaden the Company's shareholder base and international exposure, and it is part of Golden Horse's international strategy. Listing on the Frankfurt Stock Exchange will provide European investors with an easier access to Golden Horse's stock and will facilitate European investment.

"European investors have a strong interest for investing in both steel and manufacturing companies. Particularly Chinese companies with projects where there is leverage to rising commodity prices plus the blue-sky potential of an aggressive expansion program that can significantly increase revenues. This new listing provides the company with increased exposure to worldwide capital markets," says Qiang Ma, President of China Jiangsu Golden Horse Steel Ball, Inc.

The Frankfurt Stock Exchange is the world's third largest organized Exchange-trading market in terms of turnover and dealings in securities. It ranks third in the world behind NYSE and NASDAQ. It is owned and operated by Deutsche Borse, which also owns the European futures exchange Eurex and clearing company Clearstream. For more information on Frankfurt Stock Exchange please visit www.exchange.de.

Golden Horse along with its affiliates and controlled entities is one of the top five manufacturers of steel ball bearings in China. The Company produces over three billion ball bearings annually of various specifications along with its development of over 15 new products, such as stainless steel balls, aluminum balls, and ceramics balls. In addition, the Company continues to export its products to over twenty countries worldwide including the USA, Japan, Brazil, India, and Germany.

For more info: http://cvbt.realpennies.com

CardioVascular BioTherapeutics, Inc. (OTCBB: CVBT) is pleased to announce that its breakthrough angiogenesis therapy has been featured in the February 2008 issue of "Reader's Digest." The article, titled, "Heart Hope" by Lisa Collier Cool, refers to CVBT's therapy as a "new lease on life" for patients suffering from severe coronary heart disease who do not have any other viable treatment options. Patients such as those featured in the Reader's Digest article could benefit from this innovative treatment where conventional methods have failed them. Angiogenesis refers to the growth of new blood vessels that may help those suffering from coronary heart disease by increasing blood flow to the affected tissue.

Jim Blevins and Gail Keller, both patients of Dr. Lynne Wagoner, were what some refer to as "no option patients" for whom all of the "conventional treatments had been exhausted." Dr. Wagoner was the principal investigator in CVBT's completed Phase I Coronary Heart Disease trial. She learned of CVBT's new procedure in which its drug, containing the active protein fibroblast growth factor-1 (FGF-1), was injected into the heart thereby stimulating angiogenesis. In the article, Thomas J. Stegmann, MD, co-founder, co-president, and chief medical officer of CVBT explains, "the protein is like a seed that causes new vessels to sprout, creating a network of capillaries and small arteries." Once admitted into the trial, Gail Keller felt "thrilled and elated to finally have hope." In the article Gail continued, "I had nothing to lose, because the quality of my life was so bad." Before participating in the trial, Jim Blevins had been "dreading the future thinking that I'd go into heart failure again and only have a few years left." Jim continued, "within a few months of being treated, my energy was up at least 50 percent." Both Jim and Gail had successful outcomes from the Phase I trial and have been able to get back to activities that were once thought to be lost to them forever such as golf, biking and gardening.

Improving the quality of life for these patients through improvement of myocardial blood supply is CVBT's main objective. "We are pleased about being highlighted by Reader's Digest' for our intensive work in the field of angiogenesis therapy," said Dr. Stegmann. "Our goal is to provide a viable treatment that gives heart disease patients hope and can return them to the quality of life they once enjoyed."

The Phase II study will utilize an injection catheter to deliver the drug to ischemic regions in the heart wall without surgery. It is less invasive than the surgical delivery of the drug used in the Phase I trial. The Phase II trial will also permit the comparison of the benefits of CVBT's drug candidate with the requirement of a placebo control group. CardioVascular BioTherapeutics is expected to begin its Phase II clinical trial of its drug candidate CVBT-141H for the treatment of severe coronary heart disease in the coming months. For more details please visit www.cvbt.com.

Gran Tierra Energy Inc. (OTCBB: GTRE - http://finance.yahoo.com/q?s=GTRE.OB ) (Wed, January 9th, 2008, 8:30am ET) Gran Tierra Energy Inc., a company focused on oil exploration and production in South America, today announced that its net after royalty production at the end of 2007 had risen to approximately 3,300 barrels of oil per day (BOPD) as a result of growing production capacity from exploration drilling success during the year.

Average oil production in Colombia has grown to approximately 2,700 BOPD, net after royalty, compared to 2,000 BOPD reported in November 2007. This continued growth in production is the result of expanded well production capacity and infrastructure handling capacity. Average oil production in Argentina has remained stable at approximately 600 BOPD, net after royalty.

Gran Tierra Energy has an active development drilling and exploration drilling campaign budgeted for 2008. This includes six development wells in oil discoveries made in Colombia in 2007, and three oil exploration wells, two in Colombia and one in Argentina.

"Gran Tierra Energy has had exceptional exploration success in 2007 which is currently being developed and is resulting in substantial growth in production. We will be continuing our development drilling through 2008 to increase our production capacity, in addition to undertaking additional oil exploration efforts to further define the potential of our acreage in Colombia, Argentina and Peru," stated Dana Coffield, President and Chief Executive Officer of Gran Tierra Energy Inc.

For more info: http://wman.realpennies.com

Wellman, Inc. (Pink Sheets: WMAN) (January 8, 2008) announces the promotion of Mark Ruday to Chief Operating Officer reporting to Tom Duff, Wellman's Chief Executive Officer and Chairman of the Board of Wellman, Inc. Mr. Duff stated, "Mark has provided important leadership and this promotion formalized the role he was performing. His leadership will help maintain our focus on business operations while exploring strategic alternatives for the Company. We expect that he will continue to add significant value to the Company in his new position."

Reporting to Mr. Ruday will be Steve Ates, Vice President of Sales and Marketing, Ian Shaw, Vice President of Manufacturing and Research & Development, and Barry Taylor, Vice President of Human Resources and Safety, Health, and Environmental.

Mr. Ruday has held various operations and accounting positions in the Company, including his current position of Vice President, Business Operations and prior to that as Vice President, Controller and Chief Accounting Officer. He is a graduate of Brown University with a dual degree in Economics and Organizational Behavior & Management and received a Masters Degree in Accounting from Bryant College.

Read our full disclaimer at: http://www.realpennies.com/start.html

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com